NEW YORK (Reuters) - Johnson & Johnson has cautioned doctors not to begin treatment with its Doxil cancer drug because of shortages of the medicine made by an outside manufacturer. The company had ...
Generic Doxil is indicated for the treatment of ovarian cancer, acquired immune deficiency syndrome-related Kaposi’s Sarcoma and multiple myeloma. Lupin is launching doxorubicin hydrochloride liposome ...
Lupin’s alliance partner, ForDoz has received approval from the Food and Drug Administration for doxorubicin hydrochloride liposome injection, 20 mg/10 mL (2 mg/mL) and 50 mg/25 mL (2 mg/mL) ...
FDA approves generic Doxil A generic formulation of the anticancer agent Doxil has been approved to relieve ongoing shortages of the name brand medication. HealthDay News — The FDA has approved a ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results